Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
11 2020
Historique:
received: 29 11 2019
revised: 08 02 2020
accepted: 11 02 2020
pubmed: 8 3 2020
medline: 30 6 2021
entrez: 8 3 2020
Statut: ppublish

Résumé

To establish the benefits of an early, tailored and low-cost exercise intervention in older patients hospitalised for acute coronary syndrome (ACS). The study was a multicentre, randomised assessment of an exercise intervention in patients with ACS ≥70 years with reduced physical performance (as defined by the short physical performance battery (SPPB), value 4-9). The exercise intervention included four supervised sessions (1, 2, 3, 4 months after discharge) and home-based exercises. The control group attended a health education programme only. The outcomes were the 6-month and 1-year effects on physical performance, daily activities, anxiety/depression and quality of life. Finally, 1-year occurrence of adverse events was recorded. Overall, 235 patients with ACS (median age 76 (73-81) years) were randomised 1 month after ACS. Exercise and control groups were well balanced. Exercise intervention improved 6-month and 1-year grip strength and gait speed. Exercise intervention was associated with a better quality of life (as measured by EuroQol-visual analogue scale at 6 months 80 (70-90) vs 70 (50-80) points, p<0.001 and at 1 year 75 (70-87) vs 65 (50-80) points, p<0.001) and with a reduced perception of anxiety and/or depression (6 months: 21% vs 42%, p=0.001; 1 year 32% vs 47%, p=0.03). The occurrence of cardiac death and hospitalisation for cardiac cause was lower in the intervention group (7.5% vs 17%, p=0.04). The proposed early, tailored, low-cost exercise intervention improves mobility, daily activities, quality of life and outcomes in older patients with ACS. Larger studies are needed to confirm the clinical benefit. NCT03021044.

Identifiants

pubmed: 32144189
pii: heartjnl-2019-316349
doi: 10.1136/heartjnl-2019-316349
doi:

Banques de données

ClinicalTrials.gov
['NCT03021044']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1658-1664

Subventions

Organisme : RRD VA
ID : IK6 RX002477
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Gianluca Campo (G)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy cmpglc@unife.it.

Elisabetta Tonet (E)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Giorgio Chiaranda (G)

Department of Public Health, AUSL Piacenza, and Sport Medicine Service, Piacenza, Italy.

Gianluigi Sella (G)

Sports Medicine Center, AUSL Ravenna, Ravenna, Italy.

Elisa Maietti (E)

Department of Medical Science, University of Ferrara, Ferrara, Italy.

Giulia Bugani (G)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Francesco Vitali (F)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Matteo Serenelli (M)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Gianni Mazzoni (G)

Public Health Department, Azienda USL di Ferrara, Ferrara, Italy.

Rossella Ruggiero (R)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Giovanni Villani (G)

Cardiology Unit, Ospedale S, Giovanni da Saliceto, Piacenza, Italy.

Simone Biscaglia (S)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Rita Pavasini (R)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Andrea Rubboli (A)

Sports Medicine Center, AUSL Ravenna, Ravenna, Italy.
Division of Cardiology, S. Maria Delle Croci Hospital, Ravenna, Italy.

Roberta Campana (R)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Serena Caglioni (S)

Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy.

Stefano Volpato (S)

Department of Medical Science, University of Ferrara, Ferrara, Italy.

Jonathan Myers (J)

School of Medicine, Stanford University, Stanford, California, USA.
Division of Cardiology, VA Palo Alto Health Care System, Palo Alto, California, USA.

Giovanni Grazzi (G)

Public Health Department, Azienda USL di Ferrara, Ferrara, Italy.
Center of Sport and Exercise Sciences, University of Ferrara, Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH